Company: ACHV
Filing Date: 2025-03-11
Form Type: 10-K
Source: 0000950170-25-036831
Chunk: 3

Company: ACHIEVE LIFE SCIENCES, INC.
Filing Date: 2025-03-11
Form: 10-K
Item: Item 12
Chunk 3
---
The following table sets forth certain information regarding our equity compensation plans as of December 31, 2024: 

    (a)

    (b)

    (c)

    Number of securities

    remaining available for

    Number of securities to be

    future issuance under

    issued upon exercise of

    Weighted-average

    equity compensation

    outstanding options,

    exercise price of

    plans (excluding

    restricted stock units,

    outstanding options,

    securities reflected in

    Plan category
     
    warrants and rights

    warrants and rights

    column (a))

    Equity compensation plans approved by security holders

    2,939,164
     
    (1)
    $
    1.25
     
    (1)
     
    41,511
     
    (1)

    Equity compensation plans not approved by security   holders(2)

    484,000

    $
    4.99

    901,000

    Total

    3,423,164

    $
    11.97

    942,511

(1)As of December 31, 2024, we maintained the following equity compensation plans, which were approved by security holders: (a) the 2010 Performance Incentive Plan, (b) the 2017 Equity Incentive Plan, (c) the 2018 Equity Incentive Plan and (d) the 2023 Non-Employee Director Equity Incentive Plan. 

(2)Stock options granted under our 2024 Equity Inducement Plan as inducements to new employees for entering into employment agreements with us in accordance with Nasdaq Listing Rule 5635(c)(4).

The remaining information required by this Item is set forth in our 2025 Proxy Statement to be filed with the SEC within 120 days of December 31, 2024, and is incorporated by reference into this Annual Report on Form 10-K.